The Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study

被引：0
|
作者：
Aziz, Aamir Abdul [1 ]
Khan, Hannah [1 ]
Abbey, Ashkan Michael [2 ]
Almeida, David R. P. [3 ]
Avery, Robert L. [4 ]
Banda, Himanshu K. [5 ]
Barakat, Mark [6 ]
Bhandari, Ramanath [7 ]
Chang, Emmanuel Y. [8 ]
Haug, Sara [9 ]
London, Nikolas J. S. [10 ]
Sheth, Veeral [11 ]
Wolfe, Jeremy [12 ]
Singer, Michael Andrew [13 ]
Danzig, Carl J. [14 ]
Khanani, Arshad M. [1 ,15 ]
机构：
[1] Univ Nevada, Reno Sch Med, Reno, NV USA
[2] Texas Retina Associates, Dallas, TX USA
[3] Erie Retinal Surg Inc, Erie, PA USA
[4] Calif Retina Consultants, Santa Barbara, CA USA
[5] Sound Retina, Tacoma, WA USA
[6] Retinal Consultants Arizona, Phoenix, AZ USA
[7] Springfield Clin Eye Inst, Springfield, IL USA
[8] Retina & Vitreous Texas, Houston, TX USA
[9] Southwest Eye Consultants, Durango, CO USA
[10] Retina Consultants San Diego, San Diego, CA USA
[11] Univ Retina, Chicago, IL USA
[12] Associated Retinal Consultants, Royal Oak, MI USA
[13] Med Ctr Ophthalmol Associates, San Antonio, TX USA
[14] Rand Eye Inst, Deerfield, FL USA
[15] Sierra Eye Associates, Reno, NV USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results
    Arshad M. Khanani
    Aamir A. Aziz
    Hannah Khan
    Ashwin Gupta
    Ohidul Mojumder
    Aigerim Saulebayeva
    Ashkan M. Abbey
    David R. P. Almeida
    Robert L. Avery
    Himanshu K. Banda
    Mark R. Barakat
    Ramanath Bhandari
    Emmanuel Y. Chang
    Sara J. Haug
    Nikolas J. S. London
    Luke Mein
    Veeral S. Sheth
    Jeremy D. Wolfe
    Michael A. Singer
    Carl J. Danzig
    [J]. Eye, 2023, 37 : 3574 - 3581
  • [2] The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study-6 month results
    Khanani, Arshad M.
    Aziz, Aamir A.
    Khan, Hannah
    Gupta, Ashwin
    Mojumder, Ohidul
    Saulebayeva, Aigerim
    Abbey, Ashkan M.
    Almeida, David R. P.
    Avery, Robert L.
    Banda, Himanshu K.
    Barakat, Mark R.
    Bhandari, Ramanath
    Chang, Emmanuel Y.
    Haug, Sara J.
    London, Nikolas J. S.
    Mein, Luke
    Sheth, Veeral S.
    Wolfe, Jeremy D.
    Singer, Michael A.
    Danzig, Carl J.
    [J]. EYE, 2023, 37 (17) : 3574 - 3581
  • [3] Real-world efficacy of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review
    Nasimi, Nasratullah
    Nasimi, Safiullah
    Grauslund, Jakob
    Vergmann, Anna Stage
    Subhi, Yousif
    [J]. INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2024, 10 (01)
  • [4] Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Quah, Nicole Q. X.
    Javed, Khawaja Muhammad Ammar Ali
    Arbi, Lamees
    Hanumunthadu, Daren
    [J]. CLINICAL OPHTHALMOLOGY, 2024, 18 : 1479 - 1490
  • [5] Real-World Weekly Efficacy Analysis of Faricimab in Patients with Age-Related Macular Degeneration
    Muth, Daniel R.
    Fasler, Katrin F.
    Kvanta, Anders
    Rejdak, Magdalena
    Blaser, Frank
    Zweifel, Sandrine A.
    [J]. BIOENGINEERING-BASEL, 2024, 11 (05):
  • [6] Eligibility for faricimab in a real-world neovascular age-related macular degeneration population: a cross-sectional study
    Jern, Irene
    Forsell, Sara
    Norberg, Helena
    [J]. BMJ OPEN, 2022, 12 (09):
  • [7] Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration
    Hoseok Yeom
    Hye Ji Kwon
    Yoon Jeon Kim
    Junyeop Lee
    Young Hee Yoon
    Joo Yong Lee
    [J]. Scientific Reports, 13
  • [8] Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration
    Yeom, Hoseok
    Kim, Yoon Jeon
    Lee, Junyeop
    Yoon, Young Hee
    Lee, Joo Yong
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [9] Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration
    Yeom, Hoseok
    Kwon, Hye Ji
    Kim, Yoon Jeon
    Lee, Junyeop
    Yoon, Young Hee
    Lee, Joo Yong
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [10] Real-World Data on Faricimab Switching in Treatment-Refractory Neovascular Age-Related Macular Degeneration
    Ng, Benjamin
    Kolli, Hema
    Kumar, Naduviledeth Ajith
    Azzopardi, Matthew
    Logeswaran, Abison
    Buensalido, Julius
    Mushtaq, Bushra
    Chavan, Randhir
    Chong, Yu Jeat
    [J]. LIFE-BASEL, 2024, 14 (02):
12345